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NEURONAL DEVELOPMENT: ORDER AND DISORDER
CRISPR/CAS9-INDUCED INACTIVATION OF THE AUTISM
RISK GENE SETD5 LEADS TO SOCIAL IMPAIRMENTS IN
ZEBRAFISH
C. Gabellini1, D. Martini1, C. Pucci1,2, C. Di Lauro1, W. Norton3, 
A. Zippo4,5, V. Broccoli6,7, A. Sessa6, M. Andreazzoli1
1Dep. of Biology, University of Pisa and 2Sant’Anna School of
Advanced Studies, Pisa, Italy; 3Dep. of Neuroscience, Psychology
and Behaviour, University of Leicester, UK; 4National Ins. of
Molecular Genetics, Milan, Italy; 5Lab. of Chromatin Biology &
Epigenetics, Center for Integrative Biology (CIBIO), University of
Trento, Italy; 6Stem Cell and Neurogenesis Unit, Div. of
Neuroscience, San Raffaele Scientific Inst. and 7CNR Inst. of
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The SETD5 gene encodes for a putative histone H3 methyltrans-
ferase whose loss-of-function (LoF) mutations in humans have
been recently associated to intellectual disability (ID) and autis-
tic spectrum disorders (ASD). The aim of this study is to gener-
ate and characterize zebrafish models in which setd5 has been
knocked down or knocked out. setd5 is expressed at early devel-
opmental stages while at later stages its expression is localized
to the developing central nervous system (CNS) of zebrafish lar-
vae. setd5 morphant embryos are characterized by microcephaly,
cardiac edema and reduced locomotor behavior. setd5 knock-
down determined a reduction of the expression domain of CNS
specification markers paralleled by a reduced brain size com-
pared to control embryos, associated to increased apoptosis.
Furthermore, we generated stable setd5 mutant zebrafish lines
through Crispr/Cas9 strategy: setd5 LoF causes microcephaly, a
significant reduction of body length and locomotor activity.
Moreover, we characterized the behaviorial features of heterozy-
gous setd5 LoF adults, focusing on social interaction. In partic-
ular, in a social preference test, setd5 heterozygous adults
showed reduced sociality when compared to wild type siblings
and these altered behavioral traits triggered by setd5 LoF are
ameliorated by risperidone, an antipsychotic drug commonly used
to treat behavioral traits in ASD patients.
These zebrafish models will be extremely useful to identify the
molecular mechanisms underlying SETD5 LoF phenotype. The
future perspective is to screen for targeted compounds able to
rescue the developmental and behavioral defects, to identify
novel promising therapeutic compounds for individuals affected
by ASD and ID due to SETD5 haploinsufficiency.
NEURITIN IN MOUSE NEURONAL DEVELOPMENT: A
NEW THERAPEUTIC TARGET FOR RETT SYNDROME? 
E. Corti, E. Tongiorgi, G. Baj 
Lab. of Cellular and Developmental Neurobiology, University of
Trieste – Department of Life Sciences, Trieste, Italy
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Rett syndrome (RTT) is a genetic X-linked, progressive neurode-
velopmental disorder mainly caused by sporadic mutations in the
MECP2 gene. In RTT, neuronal development and synaptic cou-
pling are incomplete. In mice, MeCP2 ablation causes neuronal
dysfunctions and morphological aberrations, including brain
atrophy. The current hypothesis is that neuronal atrophy in RTT
is caused by reduced synaptic activity leading to poor trophic
support of the neuronal dendritic arborization and spines.
Among the potential neurotrophic factors candidates to rescue
neuronal atrophy, Neuritin has recently emerged for its ability to
promote growth and stabilization of axonal and dendritic arbors,
synapse formation and maturation during development. Aim of
this study is to characterize the expression of Neuritin in WT and
MeCP2 KO or heterozygous mice brains in order to ascertain a
possible disregualtion in the animal model of the pathology and
investigate its effects on RTT neuronal atrophy. 
During development, neuronal processes explore their environ-
ment to identify appropriate partners before establishing presy-
naptic and postsynaptic contacts leading to formation of stable
synapses. We previously showed that this process can be repro-
duced in vitro, in primary mouse hippocampal neuronal cultures
that achieve a mature state through 6 developmental stages.
Using this in vitro model, we previously identified the develop-
mental stages at which neuronal atrophy (days in vitro, DIV, 9-
12) and synaptic uncoupling (DIV 15) occur in RTT neurons. In
this study, we are investigating the expression of Neuritin in WT
and KO brains and testing its ability to counteract neuronal atro-
phy in MecP2 KO neurons in vitro. Preliminary results show that
levels of Neuritin in mouse whole brains at post natal day 42 are
unchanged while data from primary hippocampal cultures at 12
DIV show an mRNA reduction in these neurons. These prelimi-
nary results, suggest that Neuritin is disregulated in RTT during
development but not in the adult brains. 
DEVELOPMENT OF SEROTONERGIC FIBERS IN THE
POST-NATAL MOUSE BRAIN
A. Bertero1,2, G. Maddaloni1, M. Pratelli1, N. Barsotti1, 
A. Boonstra1, A. Giorgi1,2, S. Migliarini1 M. Pasqualetti1
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University of Pisa, Italy; 2Istituto Italiano di Tecnologia, Center
for Neuroscience and Congnitive Systems, Rovereto (TN), Italy 
Raphe nuclei serotonergic neurons provide a diffuse innervation
of the central nervous system and are involved in the modulation
of several functions in both developing and adult brain.1,2
Classical studies have described the post-natal development of
serotonergic axons as a linear process of terminal field innerva-
tion.3,4 However, technical limitations have hampered a fine mor-
phological characterization. We used the Tph2GFP knock-in
mouse line, in which GFP expression allows a specific labelling of
serotonergic neurons and axons,5 for confocal microscope imag-
ing, and we performed 3-dimensional reconstruction to morpho-
logically describe the development of serotonergic fibers in spec-
ified brain targets from birth to adulthood. Our analysis high-
lighted region-specific developmental patterns of serotonergic
fiber density ranging from a linear and progressive colonization
of the target to a transient increase in fiber density occurring
with a region-specific timing. Despite a common pattern of early
post-natal morphological maturation in which a progressive
rearrangement from a dot-shaped to a regular and smooth fiber
morphology was observed, starting from post-natal day 28 sero-
tonergic fibers acquire the regional morphological features
observed in the adult. In conclusion, we provided novel, target-
specific insights on the morphology and temporal dynamics of
the developing serotonergic fibers.
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